Microfluidics and microenvironment
Van derden11/09/19
CSEM, the Molecular Evolution Lab of the University of Basel, and the cluster Toolpoint for Lab Science join forces to organize the 2nd Basel Microfluidics and Microenvironment Forum at BASEL LIFE. As in the previous year, the forum will focus on the preparation of microphysiological systems in a microenvironment for boosting the relevance of in-vitro assays towards in-vivo outcome. This includes developments related to organ or model organism on a chip, droplet microfluidics or bioprinting. Newest technological developments and critical insights from the end users will come together at this forum. The forum brings together scientists, entrepreneurs and managers in these fields, from both industry and academia, to exchange ideas and to promote innovation applicable to bio-pharmaceutical development.
More information
Program
10.00
Introduction
10.10
Organ-on-a-Chip systems: Integrated microphysiological platforms recapitulating complex human biology
Prof. Dr. Peter Loskill (Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB, Stuttgart, DE)
10.35
Tissue engineering of functional human skeletal muscle models for drug screening using 3D bioprinting
Dr. Hansjörg Keller (Novartis Institutes for BioMedical Research, Basel, CH)
11.00
Break
11.30
Parallelized long term monitoring of 3D tissues
Dr. Vincent Revol (CSEM, Alpnach, CH)
Dr. Oliver Frey (Insphero, Schlieren, CH)
11.50
Next generation cell culture: Enhancing tissue complexity in perfused microfluidic chips
Dr. Paul Vulto (Mimetas, Leiden, NL)
12.10
BI/OND: Versatile Organ-on-Chip Platform
Dr. Nikolas Gaio (BI/OND, Delft, NL)
12.45
Lunch break & Industry Symposia
14.00
Microfluidic cell cultivation and analysis
Prof. Dr. Petra Dittrich (ETHZ Basel, Department of Biosystems Science and Engineeringm Basel, CH)
14.20
3D Cell Culture for Discovery of Prostate Cancer Biomarkers for Liquid Biopsy Diagnostics
Dr. Chris Millan (CellSpring, Schlieren, CH)
14.40
Applying Multi-Organ-Chip Technology in Safety and Efficacy Testing: How far have we come?
Dr. Reyk Horland (TissUse, Berlin, DE)
15.00
Break
15.30
Applications of renal and cardiovascular models in drug discovery
Dr. Stefan Platz (AstraZeneca, UK/CH)
15.55
Case studies for the characterisation of chemical metabolism in a microphysiological system combining skin and liver organ models
Dr. Jochen Kühnl (Beiersdorf AG, Hamburg, DE)
